The objective of this study was to investigate the incidence and density of Demodex folliculorum in the patients with rheumatoid arthritis (RA). Forty-one patients with RA and twenty-seven age and sex matched healthy controls were enrolled in this study. Disease Activity Score (DAS 28) was used for the assessment of disease activity. Out of 41 patients, 33 were females and 8 males. The mean disease duration was 10.9 ± 8.2 years. The mean DAS 28 was 3.8 ± 1.2. No statistically significant differences in the incidence and density of Demodex mites were found between patients with RA and controls. Although immunosuppression is thought to be a risk factor for the D. folliculorum infestation no such correlations could be found in the 41 immunosuppressed patients with RA, therefore, further studies with larger groups are needed.
Introduction
Demodex mites are common inhabitants of normal hair follicles and sebaceous glands (Sakuntabhai and Timpatanapong 1991 , Baima and Sticherling 2002 , Seyhan et al. 2004 . Humans are the specific host for two species: Demodex folliculorum and D. brevis. D. folliculorum is more common than D. brevis. While D. folliculorum is usually located in the follicular infundibulum, D. brevis inhabits the deeper sebaceous and meibomian glands (Jansen et al. 2001, Baima and Sticherling 2002) . Demodex mites can be found anywhere on the skin, but most frequently appear in areas where the number of sebaceous glands is highest, such as the nose, nasolabial folds, eyelids, cheek, forehead, chin and neck (Sakuntabhai and Timpatanapong 1991 , Jansen et al. 2001 , Akdeniz et al. 2002 . Most people are infested with these mites but clinical symptoms of skin demodicidosis seldom develop (Akilov and Mumcuoglu 2003) . Immunosuppression may be associated with an increase in the density of D. folliculorum and demodicidosis has been reported in children with leukaemia who are receiving chemotherapy (Patrizi et al. 1997, Damian and Rogers 2003) .
Rheumatoid arthritis (RA) is the most common inflammatory arthritis, affecting about 1% of the general population worldwide. Although RA is properly considered a disease of the joints, it can exhibit a variety of extra-articular manifestations. These manifestations clearly show that RA has features of a systemic disease that is capable of involving a variety of major organ systems (Firestein 2001) .
Rheumatoid arthritis, like many other autoimmune syndromes is a disease of adults, with the highest incidence rates reported in the elderly (Goronzy and Weyand 2003) .
In the management of RA, antirheumatic drugs auch as methotrexate, leflunomide, sulfasalazine and corticosteroids are commonly used to control the disease and most of them have immunosuppressive effects.
The aim of this study was to investigate the incidence and density of D. folliculorum in the patients with RA and to compare with those of healthy individuals.
Patients and methods
Forty-one (33 female/8 male) patients with RA and twentyseven (21 female/6 male) age and sex matched healthy controls were enrolled in this study. All patients fulfilled ACR (American College of Rheumatology) diagnostic criteria for RA. The exclusion criteria for both groups were diabetes mellitus.
Disease Activity Score (DAS 28) was used for the assessment of disease activity. Number of swollen joints, number of tender joints, erythrocyte sedimentation rate and general asSkóra Stefañski DOI: 10.2478/s11686-007-0002-7sessment of the patients with visual analog scale (VAS) were noted.
The patients with RA were divided into three groups on the basis of their DAS 28 score: patients with DAS smaller than 3.2 were included in "low disease activity group", those with DAS between 3.2 and 5.1 were included in "moderate disease activity group", and those with DAS greater than 5.1 were included in "high disease activity group". Consumption of drugs such as steroids, sulfasalazine, methotrexate, leflunomide were also noted.
Four standardized skin surface biopsies (SSSB) were taken from the cheek, forehead, nose and chin. This is a non-invasive sampling method in which the superficial part of the skin and the complete follicle contents, including mites are collected. A drop of cyanoacrylic adhesive was placed on a microscope slide, the adhesive-bearing surface of the slide was applied on the skin. The slide was then removed from the skin surface after 2 min. One to two drops of immersion oil was placed on the sample and covered with a cover slip. The slides were examined for parasites using light microscopy at a magnification of ×20 and ×40. Infestation was defined as having $5 living parasites/cm 2 of skin.
This study was approved by the Human Research Ethics Committee of Kocatepe University. Before treatment all participants were informed of the trial and given written informed consent.
All parametric results were expressed as mean ± SD for each group. Data were analyzed by descriptive statistics; in the case of nominal variables, the differences were assessed with the χ 2 test. Intergroup comparisons between the mean D. folliculorum densities were made using the Mann-Whitney U-test. Local statistical significance was assumed as P<0.05 for all parameters.
Results
Age of the patients with RA ranged between 23 and 75 years and the mean age was 54.4 ± 13.6. The mean disease duration was 10.9 ± 8.2 years. The mean DAS 28 was 3.8 ± 1.2. All patients with RA were using disease modifying drugs (DMDs) for at least one year: 16 patients were using methotrexate, 16 sulfasalazine, 9 leflunomide and 13 steroids (Table I) . Mean used dosage for methotrexate was 10.0 ± 3.4 mg/week, 20 mg/day for leflunomide, and 1.9 ± 0.2 g/day for sulfasalazine.
Two out of 14 patients from the "low disease activity group", with a mean DAS 28 of 2.5 ± 0.5 were infested with Demodex. Two out of 17 patients from the "moderate disease activity group", with a mean DAS 28 of 3.9 ± 0.5 were infested, while one out of 10 patients from the "high disease activity group", with a mean DAS 28 of 5.4 ± 0.5 was infested with follicle mites (Table II ). The infestation rates between the three groups were not statistically significant. No significant differences could be found between patients with RA and controls. In the latter, D. folliculorum infestation was found in two individuals.
Discussion
Demodex folliculorum belongs to the normal skin fauna and rarely causes clinical symptoms in humans. They are mainly found in the pilosebaceous glands and their density is normally less than 5 mites/cm 2 of skin (Sakuntabhai and Timpatanapong 1991, Forton and Song 1998) . Factors controlling the presence and density of D. folliculorum are poorly known (Aydingoz et al. 2000) . Apparently, under normal circumstances, there is a control mechanism limiting the population of follicle mites, however, local and systemic factors may create an environment favorable to their proliferation (Jansen et al. 2001) .
Demodicidosis occurs throughout the world, and the incidence of infestation is related to age (Sakuntabhai and Timpatanapong 1991, Forton and Song 1998) . Recent reports of demodicidosis in association with acquired immunodeficiency syndrome (AIDS) and cancer chemotherapy have suggested that immune deficiency may be associated with the multiplication of this mite (Castanet et al. 1997 , Patrizi et al. 1997 , Aydingoz et al. 2000 , Jansen et al. 2001 , Damian and Rogers 2003 .
Rheumatoid arthritis is a chronic progressive disease involving both local and systemic inflammation. In RA patient the immune system is rather activated than suppressed (Davis et al. 2002) . In this study, the incidence and density of D. folliculorum in patients with RA were not significantly different from these of controls. It is also known that due to high sebum production, incidence of D. folliculorum infestation increas-71 OEl¹ski 
D. folliculorum DAS 28 infestation
Low disease activity group 2 (14%) 2.5 ± 0.5 (n = 14) Moderate disease activity group 2 (12%) 3.9 ± 0.5 (n = 17) High disease activity group 1 (10%) 5.4 ± 0.5 (n = 10) Ihsan H. Ciftci et al. es with age and is mostly seen in 50-70 years old patients . Most of the patients in this study were above fifty years of age.
Rheumatoid arthritis is a chronic disease of complex physiopathology, occurring in immunogenetically susceptible hosts (Stastny et al. 1998) . The long duration of RA symptoms necessitates long-term follow-up and management. The traditional treatment of RA is represented by a pyramid starting with non-steriodal antiinflammatory drugs (NSAIDs) and continuing with DMDs such as antimalarials, sulfasalazine and methotrexate. Oral corticosteroids can then be used as a "bridge therapy" between NSAIDs and DMDs. According to drug history, our RA patients had used only methotrexate, sulfasalazine and leflunomide as DMDs. It is known that these three medications have immunosuppressive effects in addition to their immunomodulatory activities (Wahl et al. 1998 , Goldenber 1999 , Herman et al. 2004 . Many studies also show that treatments with methotrexate, steroid and leflunomide increase the rate of infection in patients with RA (Van der Veen et al. 1994 , Schnabel et al. 1996 , Hernandez-Cruz et al. 1998 , Lee and Chang 2003 , Ulusoy et al. 2005 . Although these drugs have immunosuppressive effects, we found no difference in D. folliculorum infestation rates between those treated and non-treated individuals. Akdeniz et al. (2002) found that D. folliculorum infestation increases in patients with diabetes mellitus. The general effects of hyperglycemia in diabetes mellitus may cause additional immune disturbances of the skin. However, immune disturbances in the skin of patients with RA are not evident. Autoimmune diseases such as RA and DMDs used in the treatment of such diseases may not cause immune disturbances in the skin.
To our knowledge, this is the first study investigating the relationship between D. folliculorum infestation and RA. Our study had some limitations: the study groups consisted of a small number of individuals, and the patients used DMDs such as methotrexate, leflunomide and sulfasalazine and not choloroquine, azathioprine, cyclosporine and other immunosuppressive drugs.
In conclusion, although immunosuppression is thought to be a risk factor for the D. folliculorum infestation, apparently this is not the case in RA patients. Further studies with larger groups are therefore needed to investigate this relationship more thoroughly.
